Impact of the COVID-19 Pandemic on Inpatient Antibiotic Use in the United States, January 2019 Through July 2022
Erin O’Leary, Melinda M. Neuhauser, Arjun Srinivasan, Heather Dubendris, Amy Webb, Minn Soe, Lauri A. Hicks, Hsiu Wu, Sarah Kabbani, Jonathan R. Edwards
Abstract
Antimicrobial use data reported to the National Healthcare Safety Network's Antimicrobial Use and Resistance Module between January 2019 and July 2022 were analyzed to assess the impact of the COVID-19 pandemic on inpatient antimicrobial use.
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)AntimicrobialMedicineAntibiotic resistance2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Emergency medicineMedical emergencyAntibioticsVirologyInfectious disease (medical specialty)Internal medicineDiseaseMicrobiologyBiologyOutbreakAntibiotic Use and ResistanceAntibiotics Pharmacokinetics and EfficacyBacterial Identification and Susceptibility Testing